𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

✍ Scribed by Silverman, L. R.

Book ID
124060383
Publisher
American Society of Clinical Oncology
Year
2002
Tongue
English
Weight
185 KB
Volume
20
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of myelodysplastic syndrome wi
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan : A Randomized Phase 2 Trial by the Cancer and Leukemia Group B (CALGB 19803)
✍ David L. Grinblatt; Daohai Yu; Vera Hars; James W. Vardiman; Bayard L. Powell; S πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 156 KB πŸ‘ 1 views

## Abstract ## BACKGROUD: The Cancer and Leukemia Group B evaluated oral topotecan administered at 2 schedules and doses for myelodysplastic syndrome (MDS). ## METHODS: Patients with previously untreated primary or therapy‐related MDS were eligible. Patients with refractory anemia (RA), RA with